In higher plants, fungi, and animals isoprenoids are derived from the meval
onate pathway. The carboxylic acid mevalonate is formed from acetyl-CoA and
acetoacetyl-CoA via the intermediate 3-hydroxy-3-methylglutaryl coenzyme A
(HMG-CoA). The four-electron reduction of HMG-CoA to mevalonate, which uti
lizes two molecules of NADPH, is the committed step in the biosynthesis of
isoprenoids. This reaction is catalyzed by HMG-CoA reductase (HMGR). The ac
tivity of HMGR is controlled through synthesis, degradation and phosphoryla
tion. The human enzyme has also been targeted successfully by drugs, known
as statins, in the clinical treatment of high serum cholesterol levels. The
crystal structure of the catalytic portion of HMGR has been determined rec
ently with bound reaction substrates and products. The structure illustrate
s how HMG-CoA and NADPH are recognized and suggests a catalytic mechanism.
Catalytic portions of human HMGR form tight tetramers, explaining the influ
ence of the enzyme's oligomeric state on the activity and suggesting a mech
anism for cholesterol sensing. (C) 2000 Elsevier Science B.V. All rights re
served.